Results 291 to 300 of about 289,858 (341)

Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA. [PDF]

World J Gastroenterol
Wang N, Min FT, Wen WB, Cui HT.
europepmc   +1 more source

PRETRANSPLANT THERAPIES FOR HCC FAIL TO COMPLETELY ERADICATE TUMOR PRIOR TO LIVER TRANSPLANTATION

, 2004
Eddie Island, James J. Pomposelli, Mohamed Akoad, Elizabeth A. Pomfret, Michael A. Simpson, W. David Lewis, Roger L. Jenkins   +6 more
openalex   +1 more source

Hepatocellular carcinoma drug resistance models. [PDF]

Cancer Cell Int
Xie X, Wang Y, Wang Z, Zhang L, Li J, Li Y.   +5 more
europepmc   +1 more source

A case of chronic HCV-positive hepatitis who was thought to suppress HCC recurrence after treated with percutaneous radiofrequency ablation against post-operative HCC recurrence, followed by interferon therapy, resulting in sustained-complete response

, 2004
Noboru Hirashima, Tomoyoshi Ohno, Ken‐ichi Ohba, H. Kondo, Tomoyuki Sakamoto, Noboru Shinkai, Seijiro Matsunaga, Atsunaga Kato, Haruhiko Nukaya, Kenji Sakakibara, Izumi Hasegawa, Yutaka Kondo, Fuminaka Sugauchi, Yasuto Tanaka, T. Kato, Etsuro Orito, Ryuzo Ueda, Masashi Mizokami   +17 more
openalex   +2 more sources

Surgical Resection in HCC

, 2018
Kevin M. Sullivan, James O. Park, Kevin P. Labadie   +2 more
openaire   +3 more sources

The association between PSCA gene polymorphism and hepatocellular carcinoma risk. [PDF]

World J Surg Oncol
Wang X, Sun X, Wang X, Wang Y, Zhao H, Ma J.   +5 more
europepmc   +1 more source

Hepatic arterial infusion chemotherapy in patients with unresectble hepatocellular carcinoma: 3-year survival update. [PDF]

Hepat Oncol
Chen S, Yu W, Wang X, Liu W.
europepmc   +1 more source

Targeting USP18 overcomes acquired resistance in hepatocellular carcinoma by regulating NCOA4 deISGylation and ferroptosis. [PDF]

Cell Death Dis
Ye S, Chen J, Zheng Y, He M, Zhang Y, Cheng Y, Leng Y, Wu E, Kong L, Zhang H.   +9 more
europepmc   +1 more source

Hepatitis B virus X protein (HBx)-mediated immune modulation and prognostic model development in hepatocellular carcinoma. [PDF]

PLoS One
Zhong J, Li Y, Liu Y, Qiao J, Wu Y, Kong X, Qi M, Lin Y, Yao Y, Jin Y, Bi C, Zhai A.   +11 more
europepmc   +1 more source

Hepatocellular carcinoma in patients without cirrhosis. [PDF]

World J Gastroenterol
Sato-Espinoza K, Valdivia-Herrera M, Chotiprasidhi P, Diaz-Ferrer J.   +3 more
europepmc   +1 more source